allergy banner

Original Article: Rhinitis, Sinusitis, and Upper Airway Disease

45 Articles

Sequential class switch recombination to IgE and allergen-induced accumulation of IgE+ plasmablasts occur in the nasal mucosa of local allergic rhinitis patients

Testera-Montes, A., Palomares, F., Jurado-Escobar, R., et al. Allergy. First published: 27 March 2022

Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro

Ong, H.H., Andiappan, A.K., Duan, K., et al. Allergy. First published: 10 March 2022

Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

Sousa-Pinto, B., Sá-Sousa, A., Vieira, R.J., et al. Allergy. First published: 08 March 2022

The prevalence of non-allergic rhinitis phenotypes in the general population: a cross-sectional study

Avdeeva, K.S., Fokkens, W.J., Segboer, C.L. and Reitsma, S. Allergy. First published: 17 January 2022

Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps

Lee, S.E., Hopkins, C., Mullol, J. et al. Allergy. First published: 16 January 2022

Development and validation of combined symptom-medication scores for allergic rhinitis

Sousa-Pinto, B., Filipe Azevedo, L., Jutel, M., et al. Allergy. First published: 21 December 2021

Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota

Zhao, Y, Chen, J, Hao, Y, et al. Allergy. First published: 04 November 2021

miR-146a enhances regulatory T-cell differentiation and function in allergic rhinitis by targeting STAT5b

Zhang, Y, Yang, Y, Guo, J, et al. Allergy. First published: 30 October 2021

A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2

Mohsen, MO, Balke, I, Zinkhan, S, et al. Allergy. First published: 08 September 2021

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials

Mullol, J., Laidlaw, T.M., Bachert, C., et al. Allergy. First published: 30 August 2021

Association between mucosal barrier disruption by pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis

Tuli, J.F., Ramezanpour, M., Cooksley, C., Psaltis, A.J., Wormald, P.-J. and Vreugde, S. Allergy. First published: 25 May 2021

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status

Fujieda, S, Matsune, S, Takeno, S, et al.Allergy. First published: 16 May 2021

Overcoming bacteriophage insensitivity in staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations

Liu, S., Zhao, Y., Hayes, A., Allergy. 2021; 76: 3446-3458

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: the @IT.2020 multicenter study

Lipp, T., Acar Şahin, A., Aggelidis, X., et al. Allergy. 2021; 76: : 3041-3052

Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma

Xie, Y., Ju, X., Beaudin, S., et al. Allergy. 2021; 76: 2797-2808

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

Hagemann, J., Onorato, G.L., Jutel, M., et al. Allergy. First published: 17 March 2021

Tear N-glycomics in vernal and atopic keratoconjunctivitis

Messina, A., Palmigiano, A., Tosto, C., et al. Allergy.2021; 76: 2500-2509

A murine model of eosinophilic chronic rhinosinusitis using the topical application of a vitamin D3 analog

Kagoya, R, Kondo, K, Kishimoto-Urata, M, et al. Allergy. 2021; 76: 1432– 1442

Stromal cells and B cells orchestrate ectopic lymphoid tissue formation in nasal polyps

Wang, Z-Z, Song, J, Wang, H, et al. Allergy. 2021; 76: 1416– 1431

Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps

Wang, M, Bu, X, Fang, G, et al. Allergy. 2021; 76: 789– 803

Cold-inducible RNA-binding protein contributes to tissue remodeling in chronic rhinosinusitis with nasal polyps

Shi, L-L, Ma, J, Deng, Y-K, et al. Allergy. 2021; 76: 497– 509

Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA

Seys, SF, De Bont, S, Fokkens, WJ, et al. Allergy. 2020; 75: 2867– 2878

CD23 expression on switched memory B cells bridges T-B cell interaction in allergic rhinitis

Yao, Y, Wang, N, Chen, C-L, et al. Allergy. 2020; 75: 2599– 2612

The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecology

Paramasivan, S, Bassiouni, A, Shiffer, A, et al. Allergy. 2020; 75: 2037– 2049

Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial

Lou, H, Huang, Y, Ouyang, Y, et al. Allergy. 2020; 75: 2026– 2036

Eleven faces of coronavirus disease 2019

Dong, X, Cao, Y-Y, Lu, X-X, et al. Allergy. 2020; 75: 1699– 1709

Coexistence of nasal reactivity to allergens with and without IgE sensitization in patients with allergic rhinitis

Eguiluz-Gracia, I, Fernandez-Santamaria, R, Testera-Montes, A, et al. Allergy. 2020; 75: 1689– 1698

Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air(®) App

Bédard, A, Antó, JM, Fonseca, JA, et al. Allergy. 2020; 75: 1672– 1688

"Whole" vs. "fragmented" approach to EAACI pollen season definitions: A multicenter study in six Southern European cities

Hoffmann, TM, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2020; 75: 1659– 1671

Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation

Kortekaas Krohn, I, Seys, SF, Lund, G, et al. Allergy. 2020; 75: 1155– 1164

Profilin is a marker of severity in allergic respiratory diseases

Ruiz-Hornillos, J, López-Matas, MA, Berges Jimeno, P, et al. Allergy. 2020; 75: 853– 861

Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naïve allergic patients and allergen-challenged mice

Roula, D, Theiler, A, Luschnig, P, et al. Allergy. 2020; 75: 392– 402

Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinitis

Tojima, I, Matsumoto, K, Kikuoka, H, et al. Allergy. 2019; 74: 2417– 2426

Determination of the minimally important difference in a nasal symptom score in house dust mite allergy

Devillier, P, Brüning, H, Bergmann, K-C. Allergy. 2019; 74: 2191– 2198

Google trends and pollen concentrations in allergy and airway diseases in France

Bousquet, J, Onorato, GL, Oliver, G, et al. Allergy. 2019; 74: 1910– 1919

Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France

Devillier, P, Molimard, M, Ansolabehere, X, et al. Allergy. 2019; 74: 1317– 1326

Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease

Takabayashi, T, Tanaka, Y, Susuki, D, et al. Allergy. 2019; 74: 1307- 1316

Safety and reproducibility of nasal allergen challenge

Eguiluz-Gracia, I, Testera-Montes, A, González, M, et al. Allergy. 2019; 74: 1125– 1134

Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis

Miyata, J, Fukunaga, K, Kawashima, Y, et al. Allergy. 2019; 74: 1113– 1124

Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis

Jonstam, K, Swanson, BN, Mannent, LP, et al. Allergy. 2019; 74: 743– 752

The hippo pathway effector Yes-associated protein promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps

Deng, H, Sun, Y, Wang, W, et al. Allergy. 2019; 74: 731– 742

Endotypes of chronic rhinitis: A cluster analysis study

Meng, Y, Lou, H, Wang, Y, et al. Allergy. 2019; 74: 720– 730

Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model

Rouyar, A, Classe, M, Gorski, R, et al. Allergy. 2019; 74: 549– 559

Atopic diseases and type I sensitization from adolescence to adulthood in an unselected population (TOACS) with focus on predictors for allergic rhinitis

Mortz, CG, Andersen, KE, Poulsen, LK, Kjaer, HF, Broesby-Olsen, S, Bindslev-Jensen, C. Allergy. 2019; 74: 308– 317

Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps

Zhang, Y, Derycke, L, Holtappels, G, et al. Allergy. 2019; 74: 131– 140